RxDoctor Payments DataLook up a doctor →

Elizabeth White, MD

Pediatrics · Covington, LANPI 1184604399

Payments from drug & device makers

$19,060in general payments, 2019–2025

Across 1,083 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • GSK$2K
  • Lilly USA, LLC$1K
  • Pfizer$1K
  • plus $8K from 52 others

What the payments were for

  • Consulting fees$9005%
  • Speaking & faculty fees$1501%
  • Food & beverage$17,99594%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)187$3,525
Novo Nordisk105$1,750
AstraZeneca95$1,707
GSK105$1,702
Lilly USA, LLC94$1,428
Pfizer63$1,030
Boehringer Ingelheim54$823
Bayer33$756
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC35$565
Amgen(2 entities)32$489
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$351
Takeda Pharmaceuticals U.S.A., Inc.16$310
Kowa Pharmaceuticals America, Inc.18$289
Sanofi-aventis U.S. LLC19$279
Axsome Therapeutics, Inc.10$237
Idorsia Pharmaceuticals US Inc16$223
Merck13$220
Exact Sciences10$202
Tris Pharma Inc12$195
Amarin Pharma, Inc.9$162
Johnson & Johnson10$156
Edwards Lifesciences2$156
Galderma Laboratories, L.p.1$150
Biohaven Pharmaceutical Holding Company Ltd.8$148
Eisai Inc.10$147
Biohaven Pharmaceuticals, Inc.8$146
Ironwood Pharmaceuticals, Inc9$142
Abbott7$136
Teva Pharmaceuticals USA, Inc.7$121
Esperion Therapeutics, Inc.7$117
Astellas Pharma US Inc6$108
Amneal Pharmaceuticals LLC6$101
Neos Therapeutics, LP5$92
Dexcom, Inc.4$82
Neurelis, Inc.3$82
Seqirus USA Inc5$81
Endo Pharmaceuticals Inc.4$78
Ironshore Pharmaceuticals Inc.4$72
Bausch Health US, LLC4$68
Almatica Pharma LLC3$63
Philips North America LLC1$63
Noven Therapeutics, LLC3$57
Phathom Pharmaceuticals, Inc.3$55
Sumitomo Pharma America, Inc.3$54
Optinose US, Inc.3$49
Cranial Technologies, Inc2$36
Medicure Pharma Inc.1$35
Currax Pharmaceuticals LLC2$32
Genentech USA, Inc.2$29
Vertex1$28
Shire North American Group Inc1$23
Supernus Pharmaceuticals, Inc.1$20
Renalytix AI, Inc.1$18
Sunovion Pharmaceuticals Inc.1$18
Sanofi Pasteur Inc.1$17
Circassia Inc.1$13
Otsuka America Pharmaceutical, Inc.1$13
Adlon Therapeutics L.p.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,060 in reported general payments places this provider in the 95th percentile of 913 pediatrics providers in Louisiana.

See all pediatrics providers in Louisiana

Medicare billing

Part B allowed, 2024
$131,386
Medicare patients
274
Services billed
1,889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide76$96,123
JardianceEmpagliflozin72$66,386
OzempicSemaglutide37$49,477
TrulicityDulaglutide38$41,554
EliquisApixaban62$40,462
FarxigaDapagliflozin Propanediol33$40,445
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$22,822
XareltoRivaroxaban21$22,331
JanuviaSitagliptin Phosphate14$21,955
TradjentaLinagliptin18$17,309
AbrysvoRsv Vacc, Pref A And Pref B/Pf50$16,253
Breo ElliptaFluticasone/Vilanterol26$15,967
KerendiaFinerenone19$14,489
RybelsusSemaglutide14$14,184
LinzessLinaclotide25$13,316

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,428$137,677114 claims
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$823$94,917104 claims
Novo NordiskOzempic, Rybelsus$1,750$63,66051 claims
PfizerEliquis, Abrysvo$1,030$56,714112 claims
AstraZenecaFarxiga$1,707$40,44533 claims
GSKTrelegy Ellipta, Breo Ellipta$1,702$38,79048 claims
AbbVieLinzess, Synthroid, Armour Thyroid$3,525$28,105206 claims
Johnson & JohnsonXarelto$156$22,33121 claims
MerckJanuvia$220$21,95514 claims
BayerKerendia$756$14,48919 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$101$3,462500 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 913 pediatrics providers in Louisiana.

Other pediatrics in Covington

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →